TrustCore Financial Services’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $192K | Hold |
14,632
| – | – | 0.02% | 276 |
|
|
2022
Q3 | $252K | Hold |
14,632
| – | – | 0.02% | 236 |
|
|
2022
Q2 | $161K | Hold |
14,632
| – | – | 0.02% | 277 |
|
|
2022
Q1 | $325K | Buy |
14,632
+4,727
| +48% | +$105K | 0.03% | 216 |
|
|
2021
Q4 | $341K | Hold |
9,905
| – | – | 0.04% | 196 |
|
|
2021
Q3 | $608K | Hold |
9,905
| – | – | 0.06% | 149 |
|
|
2021
Q2 | $773K | Hold |
9,905
| – | – | 0.08% | 127 |
|
|
2021
Q1 | $553K | Hold |
9,905
| – | – | 0.06% | 156 |
|
|
2020
Q4 | $606K | Hold |
9,905
| – | – | 0.08% | 136 |
|
|
2020
Q3 | $1.2M | Hold |
9,905
| – | – | 0.18% | 69 |
|
|
2020
Q2 | $1.17M | Hold |
9,905
| – | – | 0.2% | 67 |
|
|
2020
Q1 | $525K | Hold |
9,905
| – | – | 0.12% | 109 |
|
|
2019
Q4 | $539K | Buy |
9,905
+9,755
| +6,503% | +$531K | 0.1% | 122 |
|
|
2019
Q3 | $36K | Hold |
150
| – | – | 0.01% | 418 |
|
|
2019
Q2 | $34K | Buy |
+150
| New | +$34K | 0.01% | 420 |
|